NO20010981D0 - Staphylococcal immunotherapeutics via donor selection and donor stimulation - Google Patents

Staphylococcal immunotherapeutics via donor selection and donor stimulation

Info

Publication number
NO20010981D0
NO20010981D0 NO20010981A NO20010981A NO20010981D0 NO 20010981 D0 NO20010981 D0 NO 20010981D0 NO 20010981 A NO20010981 A NO 20010981A NO 20010981 A NO20010981 A NO 20010981A NO 20010981 D0 NO20010981 D0 NO 20010981D0
Authority
NO
Norway
Prior art keywords
donor
immunotherapeutics
staphylococcal
stimulation
selection
Prior art date
Application number
NO20010981A
Other languages
Norwegian (no)
Other versions
NO20010981L (en
Inventor
Joseph M Patti
Timothy James Foster
Magnus Hook
Original Assignee
Inhibitex Inc
Texas A & M Univ Sys
Trinity College Dublin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhibitex Inc, Texas A & M Univ Sys, Trinity College Dublin filed Critical Inhibitex Inc
Publication of NO20010981D0 publication Critical patent/NO20010981D0/en
Publication of NO20010981L publication Critical patent/NO20010981L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO20010981A 1998-08-31 2001-02-27 Staphylococcal immunotherapeutics via donor selection and donor stimulation NO20010981L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9844998P 1998-08-31 1998-08-31
PCT/US1999/019729 WO2000012132A1 (en) 1998-08-31 1999-08-31 Staphylococcal immunotherapeutics via donor selection and donor stimulation

Publications (2)

Publication Number Publication Date
NO20010981D0 true NO20010981D0 (en) 2001-02-27
NO20010981L NO20010981L (en) 2001-04-26

Family

ID=22269332

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010981A NO20010981L (en) 1998-08-31 2001-02-27 Staphylococcal immunotherapeutics via donor selection and donor stimulation

Country Status (6)

Country Link
EP (1) EP1121149A4 (en)
JP (1) JP2002523474A (en)
AU (1) AU762978B2 (en)
CA (1) CA2341177A1 (en)
NO (1) NO20010981L (en)
WO (1) WO2000012132A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7892552B2 (en) 2001-08-08 2011-02-22 University Of Utah Research Foundation Group B Streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
AU2001281168A1 (en) 2000-08-08 2002-02-18 St. Jude Children's Research Hospital Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
CA2434762A1 (en) 2001-01-26 2002-09-19 Joseph M. Patti Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections
MXPA03011701A (en) * 2001-06-15 2004-12-06 Nhibitex Inc Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus.
BRPI0515520A (en) 2004-09-22 2008-07-29 Glaxosmithkline Biolog Sa immunogenic composition, vaccine, methods of preparing a vaccine and preventing or treating staph infection, and use of immunogenic composition
GB0526038D0 (en) 2005-12-21 2006-02-01 Glaxosmithkline Biolog Sa Immunogenic composition
US20100021503A1 (en) 2006-03-30 2010-01-28 Glaxosmithkline Biologicals S.A. Immunogenic composition
EP2666784B1 (en) 2007-08-31 2017-04-05 University Of Chicago Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
WO2010014304A1 (en) 2008-07-29 2010-02-04 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
US20100260752A1 (en) 2009-01-23 2010-10-14 Biosynexus Incorporated Opsonic and protective antibodies specific for lipoteichoic acid of gram positive bacteria
EP2414387B1 (en) 2009-04-03 2015-12-16 University Of Chicago Compositions and methods related to protein a (spa) variants
AU2010271582B2 (en) 2009-07-15 2016-07-28 Aimm Therapeutics B.V. Gram-positive bacteria specific binding compounds
GB0913681D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
US8808699B2 (en) 2010-04-05 2014-08-19 The University Of Chicago Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response
CN103037885B (en) 2010-07-02 2015-08-26 芝加哥大学 The composition relevant to albumin A (SpA) variant and method
EP2614074A1 (en) * 2010-09-09 2013-07-17 The University of Chicago Methods and compositions involving protective staphylococcal antigens
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
US9556281B2 (en) 2011-08-15 2017-01-31 The University Of Chicago Compositions and methods related to antibodies to staphylococcal protein A
NZ702285A (en) 2012-04-26 2016-07-29 Univ Chicago Staphylococcal coagulase antigens and methods of their use
CN104703622B (en) 2012-04-26 2017-05-24 芝加哥大学 Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
GB201310008D0 (en) 2013-06-05 2013-07-17 Glaxosmithkline Biolog Sa Immunogenic composition for use in therapy
AU2014363987A1 (en) * 2013-12-09 2016-06-30 Janssen Biotech, Inc. Compositions and methods for phagocyte delivery of anti-staphylococcal agents
RU2558114C1 (en) * 2014-01-23 2015-07-27 Федеральное государственное бюджетное военное образовательное учреждение высшего профессионального образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Method for selecting donors of blood plasma applicable for treating patients with infectious diseases and postoperative, injury and burn complications
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
RU2601372C2 (en) * 2014-11-17 2016-11-10 Федеральное государственное бюджетное военное образовательное учреждение высшего профессионального образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Method for selecting donors of blood plasma using for treating patients suffering from infectious diseases and postoperative, injury and burn complications
MX2017007652A (en) 2014-12-10 2017-10-11 Glaxosmithkline Biologicals Sa Method of treatment.
RU2606377C1 (en) * 2015-10-12 2017-01-10 Федеральное государственное бюджетное военное образовательное учреждение высшего профессионального образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Method of donor blood sampling with increased content of defensins for producing monoimmunne blood plasma
AU2017218768B2 (en) 2016-02-12 2022-03-31 Janssen Pharmaceuticals, Inc. Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
RU2665170C2 (en) * 2016-12-08 2018-08-28 Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Method for treatment of patients with complications by nosocomial infections
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
KR20220107166A (en) 2019-10-02 2022-08-02 얀센 백신스 앤드 프리벤션 비.브이. Staphylococcus Peptides and Methods of Use
CN111909279B (en) * 2020-08-14 2022-06-24 石河子大学 Staphylococcus aureus and streptococcus agalactiae immunogen fusion expression and application thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK219084D0 (en) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg ANTIGEN
AU681573B2 (en) * 1991-11-22 1997-09-04 Glaxosmithkline Biologicals Sa Type I and type II surface antigens associated with (staphylococcus epidermidis)
WO1994015640A1 (en) * 1993-01-12 1994-07-21 Anthony George Gristina Methods and compositions for the direct concentrated delivery of passive immunity
US5648240A (en) * 1994-05-24 1997-07-15 Texas A&M University MHC II analog from Staphylococcus aureus
AU2192497A (en) * 1996-02-29 1998-09-18 Washington University Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof
US6288214B1 (en) * 1996-05-16 2001-09-11 Texas A&M University Systems Collagen binding protein compositions and methods of use
SE9602496D0 (en) * 1996-06-20 1996-06-20 Bengt Guss Method and means for producing a fibrinogen binding protein and its use in biotechnology
AU744723B2 (en) * 1997-01-21 2002-02-28 The Texas A & M University System Fibronectin binding protein compositions, and methods of use
AU1537699A (en) * 1997-11-26 1999-06-15 Bioresearch Ireland a division of Eolas - The Irish Science and Technology Agency Extracellular matrix-binding proteins from (staphylococcus aureus)
ES2322409T3 (en) * 1998-08-31 2009-06-19 Inhibitex, Inc. MULTICOMPONENT VACCINES AGAINST STAPHYLOCOCCUS AUREUS.

Also Published As

Publication number Publication date
AU5696699A (en) 2000-03-21
JP2002523474A (en) 2002-07-30
CA2341177A1 (en) 2000-03-09
EP1121149A4 (en) 2002-03-20
AU762978B2 (en) 2003-07-10
WO2000012132A1 (en) 2000-03-09
EP1121149A1 (en) 2001-08-08
NO20010981L (en) 2001-04-26

Similar Documents

Publication Publication Date Title
NO20010981D0 (en) Staphylococcal immunotherapeutics via donor selection and donor stimulation
NO20021449D0 (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
BR9812128B8 (en) CATHETER IV AND CATHETER DEVICE
DK1454907T3 (en) Quninazoline and pyridopyrmidine derivatives
NO20014560D0 (en) Quinasolines and their therapeutic use
DK0906129T3 (en) Implantable medical device
DE59708527D1 (en) Implantable stimulation device
DE69727063D1 (en) IMPLANTABLE DEVICE
NO20011821D0 (en) Workspace organization and furniture system
DE69832657D1 (en) Receiving devices and receiving methods
NO20004544L (en) Improved pumping device and improved methods
DE69835254D1 (en) Receiving devices and receiving methods
DE69810184T2 (en) throttling device
NO983576D0 (en) Well treatment fluids and methods
DE69734307D1 (en) telemetry device
NO993731L (en) Pyrrolopyrazolopyrimidine compound and medicine comprising this
NO315301B1 (en) Fish sorting device and its use
DK1140952T3 (en) Phosphorus-organic compounds and their use
DE59712401D1 (en) Implantable stimulation device
IT1291496B1 (en) JEWELERY CONNECTION DEVICE
ATA185596A (en) JEWELERY
KR960036082U (en) necklace
ATA164197A (en) LYING DEVICE
UA25242A (en) ELECTROTHERAPEUTIC DEVICE
KR980003238U (en) Pain relief

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application